Lv3
400 积分 2024-11-16 加入
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
5天前
已完结
Associations between IL-23R gene polymorphism (rs10889677 A/C) and ankylosing spondylitis and rheumatoid arthritis susceptibility: A meta-analysis with trial sequential analysis
2个月前
已完结
Predicting lupus low disease activity state and remission in SLE: novel insights
4个月前
已完结
Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point
4个月前
已完结
High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus
4个月前
已完结
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
4个月前
已完结
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
4个月前
已完结
Can transcriptomics guide the management of SLE-associated APS?
4个月前
已关闭
Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial
4个月前
已完结
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
4个月前
已完结
皖公网安备34019202002308
